The role of technology in reducing health care costs. Phase II and phase III.

Abstract

In Phase I of this project, reported in SAND97-1922, Sandia National Laboratories applied a systems approach to identifying innovative biomedical technologies with the potential to reduce U.S. health care delivery costs while maintaining care quality. The effort provided roadmaps for the development and integration of technology to meet perceived care delivery requirements and an economic analysis model for development of care pathway costs for two conditions: coronary artery disease (CAD) and benign prostatic hypertrophy (BPH).Phases II and III of this project, which are presented in this report, were directed at detailing the parameters of telemedicine that influence care delivery costs and quality. These results were used to identify and field test the communication, interoperability, and security capabilities needed for cost-effective, secure, and reliable health care via telemedicine.

Smart City Healthcare Delivery Innovations: A Systematic Review of Essential Technologies and Indicators for Developing Nations

“…Engaging healthcare providers, patients, policymakers, and technology developers in smart cities is crucial for aligning healthcare technology with community needs and values [33,45,59]. Adopting a multidisciplinary strategy encompassing technical feasibility, social impact, economic viability, and environmental sustainability is essential [29,42]. By fostering collaboration among diverse stakeholders, smart cities can create healthcare solutions that are not only innovative and efficient but also responsive to the unique requirements and aspirations of their communities.…”

“…Smart cities have effectively optimized resource utilization within the healthcare system, leading to significant reductions in healthcare costs, as evidenced by studies conducted by [28][29][30]. One notable approach is the integration of IoT devices, which enable real-time collection and analysis of healthcare data.…”